UK Medicines Information
Ingenol mebutate gel (Picato▼): increased incidence of skin tumours seen in some clinical studies
Information type:
Safety alerts
Source:
Medicines and Healthcare products Regulatory Agency
Specialities:
Cancers | Skin disorders
Summary
This alert advises healthcare professionals to inform patients using ingenol mebutate gel to be vigilant for the development of any new skin lesions within the treatment area and to seek medical advice immediately should any occur.
UKMi comment
Leo Pharma have also issued a letter to healthcare professionals regarding this warning.
Related links:
Letter to Healthcare Professionals